Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and to systematically document the extent and location of tau pathology in PPA patients in vivo using the same techniques.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03283449
Study type Interventional
Source Northwestern University
Contact Seyi Adeolu
Phone 312-503-2398
Email PPA.Research@northwestern.edu
Status Recruiting
Phase Phase 1
Start date February 2016
Completion date March 30, 2024